Mar
01
Introduction Impurities in medicinal agents pose significant risks to drug safety, effectiveness, and overall stability. These contaminants can emerge from multiple phases of drug development and distribution, including the sourcing of raw materials, the intricacies of manufacturing processes, improper storage conditions, and inadequate packaging practices. During raw material sourcing, impurities may be introduced from substandard […]